diroximel fumarate · Biogen · NDA 211855
Vumerity
Earliest generic entry, as listed
29 Oct 2033
Blocked by patent: US 8669281.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8669281 | substance, product | 29 Oct 2033 |
| US 10080733 | substance, product, use U-1384 | 20 Sep 2033 |
| US 9090558 | use U-1384 | 20 Sep 2033 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026First generic approved · 211855-00112 Nov 2025
- 25 Oct 2026Generic approved · 211855-00112 Nov 2025
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 211855 · 001 · RLD | capsule, delayed release, oral | 231MG | 29 Oct 2033 |